SOCS1 negatively regulates the production of Foxp3+ CD4 + T cells in the thymus

Immunology and Cell Biology

Volumn 87, Issue 6, 2009, Pages 473-480

  Zhan, Yifan ^a   Davey, Gayle M ^a   Graham, Kate L ^b   Kiu, Hiu ^a   Dudek, Nadine L ^c   Kay, Thomas W H ^b   Lew, Andrew M ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Foxp3; IFN ; IL 7; SOCS1

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 7; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL LINEAGE; CONTROLLED STUDY; MOUSE; NONHUMAN; SPLEEN CELL; THYMOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FORKHEAD TRANSCRIPTION FACTORS; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

MUS;

EID: 69049110875     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.23     Document Type: Article

References (37)

1. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387: 921-924. (Pubitemid 27289595)
2. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997; 387: 924-929. (Pubitemid 27289596)
3. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387: 917-921.
4. Marine JC, Topham DJ, McKay C, Wang D, Parganas E, Stravopodis D et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 1999; 98: 609-616. (Pubitemid 29418952)
5. Naka T, Matsumoto T, Narazaki M, Fujimoto M, Morita Y, Ohsawa Y et al. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc Natl Acad Sci USA 1998; 95: 15577-15582. (Pubitemid 29018741)
6. Starr R, Metcalf D, Elefanty AG, Brysha M, Willson TA, Nicola NA et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci USA 1998; 95: 14395-14399. (Pubitemid 28549378)
7. Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, Sprigg NS et al. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 1999; 98: 597-608. (Pubitemid 29418951)
8. Davey GM, Heath WR, Starr R. SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens 2006; 67: 1-9. (Pubitemid 43381210)
9. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007; 7: 454-465. (Pubitemid 46834848)
10. Chong MM, Cornish AL, Darwiche R, Stanley EG, Purton JF, Godfrey DI et al. Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. Immunity 2003; 18: 475-487. (Pubitemid 36513630)
11. Cornish AL, Davey GM, Metcalf D, Purton JF, Corbin JE, Greenhalgh CJ et al. Suppressor of cytokine signaling-1 has IFN-gamma-independent actions in T cell homeostasis. J Immunol 2003; 170: 878-886. (Pubitemid 36070541)
12. Ilangumaran S, Ramanathan S, Ning T, La Rose J, Reinhart B, Poussier P et al. Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes. Blood 2003; 102: 4115-4122. (Pubitemid 37486996)
13. Davey GM, Starr R, Cornish AL, Burghardt JT, Alexander WS, Carbone FR et al. SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential. J Exp Med 2005; 202: 1099-1108. (Pubitemid 41464503)
14. Catlett IM, Hedrick SM. Suppressor of cytokine signaling 1 is required for the differentiation of CD4+ T cells. Nat Immunol 2005; 6: 715-721. (Pubitemid 41716745)
15. Egwuagu CE, Yu CR, Zhang M, Mahdi RM, Kim SJ, Gery I. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J Immunol 2002; 168: 3181-3187. (Pubitemid 34250377)
16. Inagaki-Ohara K, Sasaki A, Matsuzaki G, Ikeda T, Hotokezaka M, Chijiiwa K et al. Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice. Gut 2006; 55: 212-219. (Pubitemid 43117281)
17. Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 1999; 18: 1309-1320. (Pubitemid 29110315)
18. Qing Y, Costa-Pereira AP, Watling D, Stark GR. Role of tyrosine 441 of interferon-gamma receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation. J Biol Chem 2005; 280: 1849-1853.
19. Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M et al. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem 2001; 276: 12530-12538. (Pubitemid 37385161)
20. De Sepulveda P, Ilangumaran S, Rottapel R. Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation. J Biol Chem 2000; 275: 14005-14008. (Pubitemid 30339671)
21. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 2003; 12: 1413-1426. (Pubitemid 38037011)
22. Rui L, Yuan M, Frantz D, Shoelson S, White MF. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 2002; 277: 42394-42398. (Pubitemid 35257562)
23. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995; 181: 1519-1526.
24. Bhatia SK, Tygrett LT, Grabstein KH, Waldschmidt TJ. The effect of in vivo IL-7 deprivation on T cell maturation. J Exp Med 1995; 181: 1399-1409.
25. Ramanathan S, Gagnon J, Leblanc C, Rottapel R, Ilangumaran S. Suppressor of cytokine signaling 1 stringently regulates distinct functions of IL-7 and IL-15 in vivo during T lymphocyte development and homeostasis. J Immunol 2006; 176: 4029-4041. (Pubitemid 44264381)
26. Maraskovsky E, O'Reilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell 1997; 89: 1011-1019. (Pubitemid 127678735)
27. Tybulewicz VL. Vav-family proteins in T-cell signalling. Curr Opin Immunol 2005; 17: 267-274.
28. Cornish AL, Chong MM, Davey GM, Darwiche R, Nicola NA, Hilton DJ et al. Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells. J Biol Chem 2003; 278: 22755-22761. (Pubitemid 36830336)
29. Ilangumaran S, Ramanathan S, La Rose J, Poussier P, Rottapel R. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44 high memory T lymphocytes. J Immunol 2003; 171: 2435-2445. (Pubitemid 37025551)
30. Picca CC, Larkin III J, Boesteanu A, Lerman MA, Rankin AL, Caton AJ. Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection. Immunol Rev 2006; 212: 74-85.
31. Peffault de Latour R, Dujardin HC, Mishellany F, Burlen-Defranoux O, Zuber J, Marques R et al. Ontogeny, function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7. Blood 2006; 108: 2300-2306. (Pubitemid 44497513)
32. Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol 2007; 178: 280-290. (Pubitemid 46033611)
33. Rodewald HR, Waskow C, Haller C. Essential requirement for c-kit and common gamma chain in thymocyte development cannot be overruled by enforced expression of Bcl-2. J Exp Med 2001; 193: 1431-1437. (Pubitemid 32565972)
34. Tuosto L, Marinari B, Piccolella E. CD4-Lck through TCR and in the absence of Vav exchange factor induces Bax increase and mitochondrial damage. J Immunol 2002; 168: 6106-6112. (Pubitemid 34620027)
35. Wulfing C, Bauch A, Crabtree GR, Davis MM. The vav exchange factor is an essential regulator in actin-dependent receptor translocation to the lymphocyte-antigen-presenting cell interface. Proc Natl Acad Sci USA 2000; 97: 10150-10155. (Pubitemid 30680870)
36. Michel F, Mangino G, Attal-Bonnefoy G, Tuosto L, Alcover A, Roumier A et al. CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation. J Immunol 2000; 165: 3820-3829. (Pubitemid 32057289)
37. Pandiyan P, Lenardo MJ. The control of CD4+CD25+Foxp3+ regulatory T cell survival. Biol Direct 2008; 3: 6.